ArticleScientific reports2025
Glutamine modulates cellular size by regulating Wee1 expression.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Glutamine plays a vital role in cellular biomass synthesis, serving as a key nutrient. Cancer profoundly impacts cellular size, promoting rapid proliferation and enhanced survival. Understanding the molecular mechanisms that regulate cell size in cancer is essential for designing interventions that can disrupt these processes and inhibit tumor progression. Polyploid giant cancer cells (PGCCs) represent a distinct subpopulation of tumor cells that are implicated in tumor initiation, immortality, invasion, metastasis, and resistance to chemotherapy and radiotherapy. These cells are characterized by their markedly increased size and polyploidy, underscoring the significance of cell size regulation in cancer biology. Although glutamine is known to influence cell growth, its role in regulating cell size remains poorly understood. Wee1, a key cell cycle regulator, controls the timing of mitotic entry, and is known to modulate cell size by preventing premature division. However, the potential link between glutamine, Wee1, and cell size has not been previously explored. In the present study, we investigated the role of glutamine in regulating cellular size. We found that glutamine depletion results in a significant reduction in cell size, along with decreased Wee1 expression at both mRNA and protein levels. Additionally, transient knockdown of Wee1 also led to a reduction in cellular size, reinforcing its role as a regulator of cell size. Moreover, we observed that cytochalasin-B-induced polyploidy was diminished under glutamine-deprived conditions, further affirming the importance of glutamine in maintaining polyploidy and cell size. Overall, our findings clearly indicate that glutamine is a key mediator of cellular size, and that glutamine regulates cell size at least in part through its influence on Wee1. These insights contribute to a better understanding of metabolic control of cell size in cancer and may offer novel therapeutic opportunities.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.